JA Solar to Host Fourth Quarter and Full Year 2016 Results Conference Call on March 16, 2017
Mar 02, 2017 12:01 pm UTC| Business
BEIJING, March 02, 2017 -- JA Solar Holdings Co., Ltd. (Nasdaq:JASO) ("JA Solar" or "JA"), one of the world's largest manufacturers of high-performance solar power products, today announced that it will report its...
KVH Industries Reports Fourth Quarter and Full Year 2016 Results
Mar 02, 2017 12:01 pm UTC| Business
MIDDLETOWN, R.I., March 02, 2017 -- KVH Industries, Inc., (Nasdaq:KVHI) reported financial results for the fourth quarter and fiscal year ended December 31, 2016 today. The company will hold a conference call to discuss...
KVH Industries Reports Fourth Quarter and Full Year 2016 Results
Mar 02, 2017 12:01 pm UTC| Business
MIDDLETOWN, R.I., March 02, 2017 -- KVH Industries, Inc., (Nasdaq:KVHI) reported financial results for the fourth quarter and fiscal year ended December 31, 2016 today. The company will hold a conference call to discuss...
Chimerix Announces Fourth Quarter and Full Year 2016 Financial Results
Mar 02, 2017 12:01 pm UTC| Business
- Successful Administration of IV Brincidofovir 50 mg in Ongoing Dose Escalation Study - - Demonstrates Favorable Safety and Tolerability Profile -- Conference Call at 8:30 a.m. ET Today -DURHAM, N.C., March 02, 2017 --...
Chimerix Announces Fourth Quarter and Full Year 2016 Financial Results
Mar 02, 2017 12:01 pm UTC| Business
- Successful Administration of IV Brincidofovir 50 mg in Ongoing Dose Escalation Study - - Demonstrates Favorable Safety and Tolerability Profile -- Conference Call at 8:30 a.m. ET Today -DURHAM, N.C., March 02, 2017 --...
Recro Pharma to Present at Upcoming Investor Conferences
Mar 02, 2017 12:01 pm UTC| Business
MALVERN, Pa., March 02, 2017 -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital and ambulatory care settings, currently developing non-opioid...
Recro Pharma to Present at Upcoming Investor Conferences
Mar 02, 2017 12:01 pm UTC| Business
MALVERN, Pa., March 02, 2017 -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital and ambulatory care settings, currently developing non-opioid...
U.S. Appeals Court Allows Trump Administration to Enforce Medicaid Funding Ban on Planned Parenthood